Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 20 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

15%

3 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

12Total
Not Applicable (8)
P 2 (1)
P 3 (2)
P 4 (1)

Trial Status

Completed8
Unknown6
Active Not Recruiting2
Not Yet Recruiting2
Recruiting1
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (20)

Showing 20 of 20 trials
NCT05872698Phase 4Active Not Recruiting

Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of Oesophageal Varices Trial.

NCT05124041Not ApplicableCompleted

Goal-Directed Hemostatic Resuscitation Trial in ACLF Induced Coagulopathy

NCT06437964Not ApplicableActive Not Recruiting

Prophylactic Antibiotics in Endoscopic Secondary Prevention of Gastroesophageal Variceal Bleeding

NCT03267615Recruiting

VICIS - Vienna Cirrhosis Study

NCT04546360Completed

Spleen Stiffness Combined With Liver Stiffness Measured by 2D-SWE for the Screening of High-risk Varices in Compensated Advanced Chronic Liver Disease (CHESS2004)

NCT05227833Phase 3Completed

Vonoprazan Efficacy to Prevent Post Variceal Band Ligation Ulcer

NCT06325436Not Yet RecruitingPrimary

Objective Scores in Variceal Bleeding

NCT03130127Not ApplicableNot Yet Recruiting

Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver Cirrhosis

NCT06027970Phase 3UnknownPrimary

Efficacy of Continuous Terlipressin Therapy After Endoscopic Variceal Ligation

NCT03891849Not ApplicableWithdrawn

Macro and Microcirculatory Effects of the Combination of Norepinephrine and Octreotide for the Treatment of Cirrhotic Patients With Hemorrhagic Shock

NCT04111120Unknown

Heparin Like Effect in Acute Variceal Bleeding

NCT04640350Unknown

Risk Prediction of Bleeding in Liver Cirrhosis by Combi-elastography

NCT03459378Completed

Outcome After TIPS

NCT04207398Not ApplicableUnknownPrimary

TIPS vs. NSBB Plus Endotherapy for the Prevention of Variceal Rebleeding in NSBB Non-responders of Primary Prophylaxis

NCT04254822Not ApplicableUnknown

HVPG-Guided Therapy vs Carvedilol Plus Endotherapy for the Prevention of Esophageal Variceal Rebleeding in Cirrhotic Patients

NCT00825877Completed

Long-term Follow-up of HALT-C Sustained Virological Responders

NCT03846180CompletedPrimary

Terlipressin on Effect of Renal Function in Cirrhotic Patients With Acute Gastrointestinal Hemorrhage

NCT03720067Phase 2Unknown

Propranolol, Carvedilol and Rosuvastatin in the Prevention of Variceal Bleeding in Cirrhotic Portal Hypertension

NCT03061604Not ApplicableCompletedPrimary

RCT to Determine the Efficacy of Combining Hemospray With Medical Treatment in Acute Variceal Bleeding

NCT01783899Not ApplicableCompletedPrimary

Clinical Evaluation of Hemospray in Hemostasis of Active Variceal Bleeding

Showing all 20 trials

Research Network

Activity Timeline